JANIS SANTISTEVAN: Open Payments
NPI 1265815963 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$614 in 34 payments from 10 companies in 2025. Trend: 2023 $180 · 2024 $285 · 2025 $614
Food & beverage: $614
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $160 |
| Novo Nordisk Inc | 6 | $119 |
| SANOFI PASTEUR INC. | 3 | $91 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Lundbeck LLC | 2 | $49 |
| Exact Sciences Corporation | 2 | $31 |
| PFIZER INC. | 2 | $31 |
| Astellas Pharma US Inc | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: MOUNJARO, Ozempic, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, REXULTI, The Cologuard Plus Collection Kit, NURTEC ODT, BEYFORTUS, Veozah.
Industry payments across NM — which companies pay providers there.
